spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 20 January 2009
doi: 10.1242/jcs.037200


Journal of Cell Science 122, 453-459 (2009)
Published by The Company of Biologists 2009
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helming, L.
Right arrow Articles by Gordon, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helming, L.
Right arrow Articles by Gordon, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion

Laura Helming*, Julia Winter{ddagger} and Siamon Gordon§

Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK


Figure 1
View larger version (44K):
[in this window]
[in a new window]

 
Fig. 1. Isolation of anti-CD36 antibodies blocking cytokine-induced macrophage fusion. (A) ThioM{Phi} were labelled with CFSE and PKH26 and fusion induced by exposure to IL-4 in the presence of supernatants from three individual hybridoma lines MF2, MF3 and MF4. Macrophage fusion is represented by co-localization of the red and green fluorescent labels (yellow). (B) Quantitation of co-localization in the presence of the purified anti-CD36 antibodies MF2, MF3 and MF4 (20 µg/ml). Means±s.d. of 21 measurements combined from three independent experiments. (C) MF2, MF3, MF4 or isotype control (IgG2a, IgG2b) antibodies were covalently coupled to protein G beads and used for immunoprecipitation from ThioM{Phi} lysates. Specific bands (~100 kDa) could be detected on the silver-stained gel for MF2, MF3 and MF4 but not for isotype control antibodies. (D) Transient transfection of CHO cells with mCD36-YFP or YFP control vector, stained with MF2, 3 and 4. Positive staining was detected via anti-rat Alexa 555 (red). Positive staining with MF2, 3 and 4 was only detected in CHO cells expressing the mCd36-YFP fusion protein. (E) Western Blot analysis of wild-type (WT) and CD36-KO macrophage lysates using MF3, MF2, MF4 and anti-β-actin antibodies. ***P<0.0001, Mann Whitney Test, two-tailed.

 

Figure 2
View larger version (21K):
[in this window]
[in a new window]

 
Fig. 2. The involvement of CD36 in macrophage fusion. (A) BMM from wild-type (WT) and CD36-KO mice were induced to fuse by exposure to IL-4 and GM-CSF and stained with Hemacolor. (B) Macrophage fusion was quantified via the percentage of giant-cell nuclei relative to the total number of nuclei. (C) Fusion of wild-type and CD36-KO BMM in the presence of the anti-CD36 antibody (MF3, 20 µg/ml). (D,E) Shown are means±s.d. (n=8) *P=0.0404, ***P=0.0054 (Mann Whitney Test, two-tailed), representatives of three independent experiments are shown.

 

Figure 3
View larger version (62K):
[in this window]
[in a new window]

 
Fig. 3. The expression of CD36 during macrophage fusion. (A) FACS analysis of CD36 expression in ThioM{Phi} after incubation with IL-4 using MF3 or isotype control IgG2a (grey shade) antibodies. Anti-rat Alexa 488 was used for detection (FL1-H). (B) Confocal microscopy of lamellipodia and cell-cell contacts (arrows) formed at the onset of macrophage fusion (ThioM{Phi}, 6-8 hours). CD36 was labelled with MF3 and anti-rat Alexa 488 (green), actin with phalloidin-TRITC (red) and nuclei counterstained with DAPI (blue). (C) Lamellipodia and cell-cell contacts (arrows) in the presence of the anti-CD36 antibody MF3 (ThioM{Phi}, 8 hours) and in (D) wild-type (WT) and CD36-KO BMM (incubated for 48 hours with IL-4/GM-CSF). Bar, 10 µm.

 

Figure 4
View larger version (21K):
[in this window]
[in a new window]

 
Fig. 4. Expression of IL-4 induced markers. Real-time RT-PCR analysis of IL-4-induced markers in wild-type (WT) and CD36-KO BMM. Macrophages were stimulated for 24 hours. Means ±s.d. of duplicate reactions are shown. Arg1, Arginase 1; Chi3l3, Ym1; Tm7sf4, DC-STAMP; Retnla, Fizz1.

 

Figure 5
View larger version (35K):
[in this window]
[in a new window]

 
Fig. 5. The requirement of CD36 on one fusion partner. (A) Wild-type (WT) or CD36-KO BMM were labelled with PKH26 (red) and mixed with green CFSE-labelled wild-type ThioM{Phi} and incubated with IL-4. Cross-fusion is represented by co-localization of the fluorescent labels (yellow). (B) Quantitation of macrophage fusion, shown are means ±s.d. (n=3). Quantitation was performed twice with similar results.

 

Figure 6
View larger version (35K):
[in this window]
[in a new window]

 
Fig. 6. A role for lipid recognition by CD36 and PS exposure and recognition during macrophage fusion. Quantitation of ThioM{Phi} fusion in the presence of (A) oxLDL (50 µg/ml) or (B) PS liposomes (PS/PC, 50 µM). Means±s.d. combined from three independent experiments. (A) n=21, ***P<0.0001; (B) n=17, ***P=0.0003. Mann Whitney Test, two-tailed. (C) Binding of DiI-labelled PS liposomes (=FL2) to ThioM{Phi} can be blocked by addition of anti-CD36 antibodies (MF3) but not control antibodies (IgG2a). This result was obtained in three independent experiments. (D) ThioM{Phi} were plated with IL-4 on Permanox in the presence of annexinV-FITC for 18-24 hours. Nuclei were counterstained with DAPI. (E) Annexin V-FITC blocks IL-4 induced ThioM{Phi} fusion. Means ±s.d., n=6, **P=0.0051, Mann Whitney Test, two-tailed. Shown are representatives of three independent experiments. Bar, 10 µm.

 

Figure 7
View larger version (15K):
[in this window]
[in a new window]

 
Fig. 7. CD36 is not involved in osteoclast formation. (A) TRAP staining and (B) quantitation of fusion in osteoclasts derived from wild-type (WT) and CD36-KO bone marrow progenitors by incubation with M-CSF/RANKL for 4 days. Shown are means±s.d. (n=6). Experiment was performed twice with similar results.

 

Figure 8
View larger version (24K):
[in this window]
[in a new window]

 
Fig. 8. Proposed mechanism of the involvement of CD36 during macrophage fusion. Localized areas of PS exposure on one fusion partner (macrophage 1) are recognized by CD36 on the other fusion partner (macrophage 2). Recognition of PS is required for efficient macrophage fusion.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2009